Although it is not yet well understood how adropin levels decrease in the presence of obesity, it has been shown that adropin-knockout mice exhibit development of insulin resistance and metabolic dysregulation, and treatment with exogenous adropin, may improve these conditions [15]. Here, ENHO is linked to obesity disorder.